Neal C. Bradsher, 10% Owner at Insight Molecular Diagnostics Inc. (IMDX), bought 521,739 shares at $5.75 ($3.0M) on 2026-02-10, disclosed to the SEC on 2026-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| STAA | BUY | 2025-11-21 | $82.1M | — | Filing → |
| STAA | BUY | 2025-04-10 | $5.4M | — | Filing → |
| STAA | BUY | 2025-03-28 | $4.0M | — | Filing → |